Héléne Toinét Cronjé

9PUBLICATIONS
19CO-AUTHORS
PharmacogenomicsCardiology (incl. cardiovascular diseases)Predictive and prognostic markersComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 14, 2024
Proteomic Signatures of Genetically Predicted and Pharmacologically Observed PCSK9 Inhibition.

Jordan M Kraaijenhof, Héléne T Cronjé, G Kees Hovingh

|Aug 14, 2023
Cardiovascular Efficacy of Lipid-Lowering Drug Targets Is Not Entirely Explained by Apolipoprotein B Reduction: Mendelian Randomization Evidence.

Dipender Gill, Benjamin Woolf, Loukas Zagkos

|Aug 08, 2023
Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization.

Benjamin Woolf, Héléne T Cronjé, Loukas Zagkos

|Jul 01, 2023
Serum NfL and GFAP are associated with incident dementia and dementia mortality in older adults: The cardiovascular health study.

Héléne T Cronjé, Xiaojuan Liu, Michelle C Odden

|May 02, 2023
Role of Clonal Hematopoiesis of Indeterminant Potential-Related Germline TET2 Variation in Inflammation and Cardiovascular Disease Risk: A Mendelian Randomization Study.

Héléne T Cronjé, Dipender Gill

|Feb 07, 2023
Plasma Proteomic Risk Markers of Incident Type 2 Diabetes Reflect Physiologically Distinct Components of Glucose-Insulin Homeostasis.

Héléne T Cronjé, Michael Y Mi, Thomas R Austin

Pageof 2

Frequent Collaborators

4 joint publications

Dipender Gill

3 joint publications

Loukas Zagkos

2 joint publications

Hannah R Elliott

2 joint publications

Cornelie Nienaber-Rousseau